Xtant Medical announced FDA 510(k) clearance to market the Xsert™ Lumbar Expandable Interbody System, including an indication to be packed with autograft or allogrant bone, such as Xtant’s 3Demin and OsteoSponge.
The Xsert all-titanium device expands in situ and features nanotextured endplate surfaces to encourage osteointegration.
Initial product launch will commence in mid-2017.
Sources: Xtant Medical Holdings, Inc.; ORTHOWORLD Inc.
Xtant Medical announced FDA 510(k) clearance to market the Xsert™ Lumbar Expandable Interbody System, including an indication to be packed with autograft or allogrant bone, such as Xtant's 3Demin and OsteoSponge.
The Xsert all-titanium device expands in situ and features nanotextured endplate surfaces to encourage...
Xtant Medical announced FDA 510(k) clearance to market the Xsert™ Lumbar Expandable Interbody System, including an indication to be packed with autograft or allogrant bone, such as Xtant’s 3Demin and OsteoSponge.
The Xsert all-titanium device expands in situ and features nanotextured endplate surfaces to encourage osteointegration.
Initial product launch will commence in mid-2017.
Sources: Xtant Medical Holdings, Inc.; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





